Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Depixol
2. Flupenthixol Decanoate
3. Flupenthixol Decanoate, (z)-isomer
4. Flupentixol Decanoate
1. Flupentixol Decanoate
2. 06s5u14a4g
3. 69079-98-7
4. 30909-51-4
5. 2-[4-[(3z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethyl Decanoate
6. Decanoic Acid, 2-(4-((3z)-3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-1-piperazinyl)ethyl Ester
7. Decanoic Acid, 2-(4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-1-piperazinyl)ethyl Ester, (z)-
8. Fluanxol Depot (tn)
9. (z)-flupentixol Decanoate
10. Flupentixoldecanoate
11. Unii-06s5u14a4g
12. D07976
13. 909f514
14. Q27896258
| Molecular Weight | 588.8 g/mol |
|---|---|
| Molecular Formula | C33H43F3N2O2S |
| XLogP3 | 9.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 15 |
| Exact Mass | 588.29973428 g/mol |
| Monoisotopic Mass | 588.29973428 g/mol |
| Topological Polar Surface Area | 58.1 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 815 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Tranquilizing Agents
A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. (See all compounds classified as Tranquilizing Agents.)
ABOUT THIS PAGE
A Flupentixol Decanoate, (Z)- manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flupentixol Decanoate, (Z)-, including repackagers and relabelers. The FDA regulates Flupentixol Decanoate, (Z)- manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flupentixol Decanoate, (Z)- API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Flupentixol Decanoate, (Z)- supplier is an individual or a company that provides Flupentixol Decanoate, (Z)- active pharmaceutical ingredient (API) or Flupentixol Decanoate, (Z)- finished formulations upon request. The Flupentixol Decanoate, (Z)- suppliers may include Flupentixol Decanoate, (Z)- API manufacturers, exporters, distributors and traders.
Flupentixol Decanoate, (Z)- Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flupentixol Decanoate, (Z)- GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flupentixol Decanoate, (Z)- GMP manufacturer or Flupentixol Decanoate, (Z)- GMP API supplier for your needs.
A Flupentixol Decanoate, (Z)- CoA (Certificate of Analysis) is a formal document that attests to Flupentixol Decanoate, (Z)-'s compliance with Flupentixol Decanoate, (Z)- specifications and serves as a tool for batch-level quality control.
Flupentixol Decanoate, (Z)- CoA mostly includes findings from lab analyses of a specific batch. For each Flupentixol Decanoate, (Z)- CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flupentixol Decanoate, (Z)- may be tested according to a variety of international standards, such as European Pharmacopoeia (Flupentixol Decanoate, (Z)- EP), Flupentixol Decanoate, (Z)- JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flupentixol Decanoate, (Z)- USP).
LOOKING FOR A SUPPLIER?
